Volume 58, Issue 3, Pages 609-618 (March 2013) Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate  Matteo Cescon, Alessandro Cucchetti, Matteo Ravaioli, Antonio Daniele Pinna  Journal of Hepatology  Volume 58, Issue 3, Pages 609-618 (March 2013) DOI: 10.1016/j.jhep.2012.09.021 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Competing risk analysis of dropout from the waiting list depending on TNM stage, downstaging procedure, and response to neo-adjuvant therapy. (A) T1 patients and T2 patients with a complete response to neo-adjuvant treatments had similar dropout risks, which were lower than the risk observed for T2 patients with a partial response or no response. (B) T1 patients and T2 patients with a complete response had a dropout risk lower than that observed for patients subjected to downstaging, whose risk was in turn lower than that observed for T2 patients with a partial response or no response. (C) The dropout risk due to tumor progression is shown according to tumor stages and responses to treatments (p=0.001). (Cucchetti et al. [41] reprinted with permission). Journal of Hepatology 2013 58, 609-618DOI: (10.1016/j.jhep.2012.09.021) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions